Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/120744
Full metadata record
DC FieldValueLanguage
dc.creatorLopes, C
dc.creatorGomes, C
dc.creatorNeto, E
dc.creatorSampaio, P
dc.creatorAguiar, P
dc.creatorPêgo, AP
dc.date.accessioned2019-06-25T12:08:42Z-
dc.date.available2019-06-25T12:08:42Z-
dc.date.issued2016
dc.identifier.issn1743-5889
dc.identifier.urihttps://hdl.handle.net/10216/120744-
dc.description.abstractAim: Propose a nanoparticle for neuron-targeted retrograde gene delivery and describe a microfluidic-based culture system to provide insight into vector performance and safety. Methods: Using compartmentalized neuron cultures we dissected nanoparticle bioactivity upon delivery taking advantage of (quantitative) bioimaging tools. Results: Targeted and nontargeted nanoparticles were internalized at axon terminals and retrogradely transported to cell bodies at similar average velocities but the former have shown an axonal flux 2.7-times superior to nontargeted nanoparticles, suggesting an improved cargo-transportation efficiency. The peripheral administration of nanoparticles to axon terminals is nontoxic as compared with their direct administration to the cell body or whole neuron. Conclusion: A neuron-targeted nanoparticle system was put forward. Microfluidic-based neuron cultures are proposed as a powerful tool to investigate nanoparticle bio-performance.
dc.description.sponsorshipThe work was financed by Portuguese funds through the FCT – Fundação para a Ciência e a Tecnologia in the framework of the projects PTDC/CTM-NAN/115124/2009 and PTDC/CTM-NAN/3547/2014. CDF Lopes, CP Gomes and E Neto acknowledge the FCT for their PhD scholarships(SFRH/BD/77933/2011, SFRH/BD/77930/2011 and SFRH/BD/81152/2011, respectively). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
dc.language.isoeng
dc.publisherFuture Medicine
dc.relationinfo:eu-repo/grantAgreement/FCT/5876-PPCDTI/115124/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F77933%2F2011/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F81152%2F2011/PT
dc.relation.ispartofNanomedicine, vol. 11(24), p. 3205-3221
dc.rightsopenAccess
dc.subjectgene delivery
dc.subjectmicrofluidics
dc.subjecttargeted nanoparticles
dc.titleMicrofluidic-based platform to mimic the in vivo peripheral administration of neurotropic nanoparticles
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.2217/nnm-2016-0247
dc.relation.publisherversionhttps://www.futuremedicine.com/doi/abs/10.2217/nnm-2016-0247?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=nnm
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
Microfluidicbasedplatformtomimictheinvivo.pdf1.08 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.